Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry, has added development and manufacturing softgel capability in its Cincinnati facility, providing the pharmaceutical industry a new contract provider for this popular drug delivery system.
Subscribe to our email newsletter
Further to the addition of the new drug delivery system, the company has named Edgar Jaynes as its associate director of pharmaceutical development services.
Dr Jaynes comes to Patheon with experience in product development and manufacturing, particularly in soft gel technology. Dr Jaynes comes to Patheon from Banner Pharmacaps, where he has been for the past 14 years.
Wes Wheeler, CEO and president of Patheon, said: “We are very excited to be able to offer our customers soft gel capabilities as they look to the contract development and manufacturing industry for additional choices for this manufacturing technology.
“Adding soft gel equipment enhances our current liquid filled, hard gelatin capsule technology in Cincinnati and creates a more comprehensive service offering to our clients. We look forward to marketing this enhanced capability to our client base.
“I am also very pleased that Dr Jaynes has agreed to join the organization. We look forward to his leadership and expertise and we are confident that he will be a key addition to our Cincinnati PDS operation.”
Patheon provides products and services to approximately 300 pharmaceutical and biotechnology companies. The company’s services range from preclinical development through commercial manufacturing of a full array of dosage forms including parenteral, solid, semi-solid and liquid forms.